Growth hormone and bone health

Hormone Research

Volumn 60, Issue SUPPL. 3, 2003, Pages 80-86

  Bex, Marie ^a   Bouillon, Roger ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Bone mineral density; Growth hormone deficiency; Peak bone mass

Indexed keywords

COLLAGEN TYPE 1; ESTROGEN RECEPTOR; GLUCOCORTICOID; GROWTH HORMONE; LIPOPROTEIN RECEPTOR; SEX HORMONE; SOMATOMEDIN C; THYROID HORMONE; VITAMIN D RECEPTOR;

AGE DISTRIBUTION; BONE CELL; BONE DENSITY; BONE GROWTH; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CARTILAGE CELL; CELL PROLIFERATION; CONFERENCE PAPER; DRUG EFFECT; FEMUR NECK; FOLLOW UP; FRACTURE; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; GROWTH PLATE; HORMONE ACTION; HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; LUMBAR SPINE; NONHUMAN; ONSET AGE; OSTEOBLAST; OSTEOLYSIS; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGE FACTORS; AGE OF ONSET; ANIMALS; BODY HEIGHT; BONE AND BONES; BONE DENSITY; BONE DEVELOPMENT; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; CROSS-SECTIONAL STUDIES; FEMALE; GROWTH DISORDERS; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; LUMBAR VERTEBRAE; MALE; SOMATOMEDINS;

EID: 0347985069     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000074507     Document Type: Conference Paper

References (35)

1. Ohlsson C, Bengtsson B-Å, Isaksson OG, Andreassen TT, Slootweg MC: Growth hormone and bone. Endocr Rev 1998;19:55-79.
2. Rizzoli R, Bonjour JP: Determinants of peak bone mass and mechanisms of bone loss. Osteoporos Int 1999;suppl 2:S17-S23.
3. Uitterlinden AG, van Leeuwen JPTM, Pols HAP: Genetics and genomics of osteoporosis; in Marcus R, Feldman D, Kelsey J (eds): Osteoporosis. San Diego, Academic Press, 2001, vol 1, pp 639-667.
4. Boyden LM, Mao J, Belsky J, Mitzner L, Fahri A, Mitnick MA, Wu D, Insogna K, Lifton RP: High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med 2002;346:1513-1521.
5. Beamer WG, Donahue LR, Rosen CJ: Insulin-like growth factor I and bone: from mouse to man. Growth Horm IGF Res 2000;10(suppl B):S103-S105.
6. Rosen CJ, Dimai HP, Vereault D, Donalme LR, Beamer WG, Farley J, Linkliart S, Linkliart T, Mohan S, Baylink DJ: Circulating and skeletal insulin-like growth factor-1 (IGF-1) concentrations in two inbred strains of mice with different bone mineral densities. Bone 1997;21:217-223.
7. Sinha YN, Vlahakis G, Vanderlaan WP: Serum, pituitary and urine concentrations of prolactin and growth hormone in eight strains of mice with varying incidence of mammary tumors. Int J Cancer 1979;24:430-437.
8. Bouillon R: Growth hormone and bone. Horm Res 1991;36:49-55.
9. de Boer H, Blok GJ, van der Veen EA: Clinical aspects of growth hormone deficiency in adults. Endocr Rev 1995;16:63-85.
10. Ohlsson C, Nilsson A, Isaksson OGP, Lindahl A: Effects of growth hormone and insulin-like growth factor 1 on DNA synthesis and matrix production in rat epiphyseal chondrocytes in monolayer culture. J Endocrinol 1992;133:291-300.
11. Sims NA, Clément-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R, Goffin V, Coshigano K, Gaillard-Kelly M, Kopchick J, Baron R, Kelly PA: Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest 2000;106:1095-1103.
12. Boonen S, Mohan S, Dequeker J, Aerssens J, Vanderschueren D, Verbeke G, Broos P, Bouillon R, Baylink DJ: Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis. J Bone Miner Res 1999;14:2150-2158.
13. Baroncelli GI, Bertelloni S, Ceccarelli C, Saggese G: Measurement of volumetric bone mineral density accurately determines degree of lumbar undermineralization in children with growth hormone deficiency. J Clin Endocrinol Metab 1998;83:3150-3154.
14. Kaufman JM, Taelman P, Vermeulen A, Vandeweghe M: Bone mineral status in growth hormone-deficient males with isolated and multiple pituitary deficiencies of childhood onset. J Clin Endocrinol Metab 1992;74:118-123.
15. Boot AM, Engels MA, Boerma GJ, Krenning EP, De Muinck Keizer-Schrama SM: Changes in bone mineral density, body composition, and lipid metabolism during growth hormone (GH) treatment in children with GH deficiency. J Clin Endocrinol Metab 1997;82:2423-2428.
16. Saggese G, Baroncelli GI, Bertelloni S, Barsanti S: The effect of long-term growth hormone (GH) treatment on bone mineral density in children with GH deficiency. Role of GH in the attainment of peak bone mass. J Clin Endocrinol Metab 1996;81:3077-3083.
17. de Boer H, Blok GJ, van Lingen A, Teule GJ, Lips P, van der Veen EA: Consequences of childhood-onset growth hormone deficiency for adult bone mass. J Bone Miner Res 1994;9:1319-1326.
18. Baroncelli GI, Bertelloni S, Sodini F, Saggese G: Lumbar bone mineral density at final height and prevalence of fractures in treated children with GH deficiency. J Clin Endocrinol Metab 2002;87:3624-3631.
19. Bachrach LK: Bone mineral, histomorphometry, and body composition in adults with growth hormone receptor deficiency. J Bone Miner Res 1998;13:415-421.
20. Woods KA, Camacho-Hübner C, Bergman RN, Barter D, Clark AJ, Savage MO: Effects of insulin-like growth factor I (IGF-I) therapy on body composition and insulin resistance in IGF-I gene deletion. J Clin Endocrinol Metab 2000;4:1407-1411.
21. Maheshwari HG, Bouillon R, Nijs J, Oganov VS, Bakulin AV, Baumann G: The impact of congenital, severe, untreated growth hormone (GH) deficiency on bone size and density in young adults: Insights from genetic GH-releasing hormone receptor deficiency. J Clin Endocrinol Metab 2003;88:2614-2618.
22. Bouillon R, Prodonova A: Growth hormone deficiency and peak bone mass. J Pediatr Endocrinol Metab 2000;13:1327-1336
23. Toogood AA, Adams JE, O'Neill PA, Shalet SM: Elderly patients with adult-onset growth hormone deficiency are not osteopenic. J Clin Endocrinol Metab 1997;82:1462-1466.
24. Fernholm R, Bramnert M, Hägg E, Hilding A, Baylink DJ, Mohan S, Thorén M: Growth hormone replacement therapy improves body composition and increases bone metabolism in elderly patients with pituitary disease. J Clin Endocrinol Metab 2000;85:4104-4112.
25. Wüster C, Abs R, Bengtsson BA, Bennmarker H, Feldt-Rasmussen U, Hernberg-Stahl E, Monson JP, Westberg B, Wilton P: The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. J Bone Miner Res 2001;16:398-405.
26. Wüster C, Slenzzka E, Ziegler R: Prävalenz von Osteoporose und Arteriosklerose bei konventionell substituierter Hypophysenvorderlappeninsuffizienz: Bedarf einer zusätzlichen Wachstumshormonsubstitution? Klin Wochenschr 1991;69:249-255.
27. Rosen T, Wilhelmsen L, Landin-Wilhelmsen K, Lappas G, Bengtsson BA: Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. Eur J Endocrinol 1997;137:240-245.
28. Vestergaard P, Jörgensen JO, Hagen C, Hoeck HC, Laurberg P, Rejnmark L, Brixen K, Weeke J, Andersen M, Conceiçao FL, Nielsen TL, Mosekilde L: Fracture risk is increased in patients with GH deficiency or untreated prolactinomas - a case-control study. Clin Endocrinol (Oxf) 2002;56:159-167.
29. Bravenboer N, Holzmann P, de Boer H, Roos JC, van der Veen EA, Lips P: The effect of growth hormone (GH) on histomorphometric indices of bone structure and bone turnover in GH-deficient men. J Clin Endocrinol Metab 1997;82:1818-1822.
30. Brixen K, Hansen TB, Hauge E, Vahl N, Jörgensen JPL, Christiansen JS, Mosekilde L, Hagen C: Growth hormone treatment in adults with adult-onset growth hormone deficiency increases iliac crest trabecular bone turnover: A 1-year, double-blind, randomized, placebo-controlled study. J Bone Miner Res 2000;15:293-300.
31. Bouillon R, Daci E, Carmeliet G, Bex M: Pituitary tumours and bone; in Webb SM (ed): The Management of Pituitary Tumours. Bristol, BioScientifica, 1998, pp 191-208.
32. Brixen K, Hansen TB, Eriksen EF, Mosekilde L: Does growth hormone therapy in adult patients with growth hormone deficiency protect against bone loss? Growth Horm IGF Res 1998;(suppl A):81-86.
33. Baum HB, Biller BM, Finkelstein JS, Cannistraro KB, Oppenhein DS, Schoenfeld DA, Michel TH, Wittink H, Klibanski A: Effects of physiologic growth hormone therapy on bone density and body composition in patients with adult-onset growth hormone deficiency. A randomized, placebo-controlled trial. Ann Intern Med 1996;125:883-889.
34. Bex M, Abs R, Maiter D, Beckers A, Lamberigts G, Bouillon R: The effects of growth hormone replacement therapy on bone metabolism in adult-onset growth hormone deficiency: A 2-year open randomized controlled multicenter trial. J Bone Miner Res 2002;17:1081-1094.
35. Sneppen SB, Hoeck HC, Kollerup G, Sorensen OH, Laurberg P, Feldt-Rasmussen U: Bone mineral content and bone metabolism during physiological GH treatment in GH-deficient adults - an 18-month randomised, placebo-controlled, double blinded trial. Eur J Endocrinol 2002;146:187-195.